Pvs28, a vaccine candidate for blocking transmission of plasmodium vivax

Type
Compound(s)

Pvs28, a vaccine candidate for blocking transmission of plasmodium vivax This invention relates to methods for preventing transmission using PVs28 polypeptide of malaria by eliciting an immune response against parasites responsible for the disease. The Pvs28 polypeptide which is isolated from Plasmodium vivax can be administered to a susceptible organism to prevent transmission of malaria. Claims in this application are drawn to the Pvs28 polypeptide, the nucleic acid molecule which encodes Pvs28, pharmaceutical compositions containing Pvs28, and methods of inducing an immune response against Pvs28.

Disease
Malaria
Research areas
Basic research
Vaccine
Condition of use

n/a

IP information

Abandoned Patent Reference Number(s): 60/045,283